ELMD - Earnings announcements

18% Revenue growth and strong operating leverage exceeds consensus expectations for the third quarter of fiscal 2026 Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and nine months ended March 31, 2026 ("Q3 FY 2026"). Q3 FY 2026 Company Highlights Net revenues increased 18.4% to a record $18.6 million in Q3 FY 2026, from $15.7 million in the third quarter of the prior fiscal year, led by an 18.6% increase in the core homecare market. Operating income increased to a record $3.8 million, a 76.0% increase from the third quarter of the prior fiscal year, and 20.3% of net revenues. Net

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 third quarter ended March 31, 2026, on Tuesday, May 12, 2026 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780. The live webcast of the call will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Fiscal Q3 2026 Earning

Strong operational execution results in thirteenth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2025 ("Q2 FY 2026"). Q2 FY 2026 Company Highlights Net revenues increased 16.3% to a record $18.9 million in Q2 FY 2026, from $16.3 million in the second quarter of the prior fiscal year, led by an 18.4% increase in the core homecare market. Operating income increased to a record $3.6 million, a 42.4% increase from the second quarter of the prior fiscal year. Operating margin improve

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 second quarter ended December 31, 2025, on Tuesday, February 10, 2026 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live webcast of the call will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electrome

Strong operational execution results in twelfth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2025 ("Q1 FY 2026"). Q1 FY 2026 Company Highlights Net revenues increased 15.1% to $16.9 million in Q1 FY 2026, from $14.7 million in the first quarter of the prior fiscal year. Operating income increased to $2.7 million, a 37.8% increase from the first quarter of the prior fiscal year. Net income was $2.1 million, or $0.25 per diluted share, representing an increase of 44.9%, compared to

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 first quarter ended September 30, 2025, on Wednesday, November 12, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Ele

Record quarterly and annual revenues and operating income, marking the eleventh consecutive quarter of year-over-year revenue and operating income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2025") and full year ended June 30, 2025 ("FY 2025"). Q4 FY 2025 Company Highlights Net revenue increased 17.3% to a record $17.4 million in Q4 FY 2025, from $14.8 million in the fourth quarter of the prior fiscal year. Operating income was a record $3.0 million, a 30.2% increase from the fourth quarter of the prior fiscal year. Net income was $2.2 million, or $0.25 p

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2025 fourth quarter ended June 30, 2025, on August 26, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Q4 FY 202

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2025 third quarter ended March 31, 2025, on May 13, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Q3 Fiscal 2025

Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple strategic growth initiatives Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2024 ("Q2 FY 2025"). Q2 FY 2025 Company Highlights Net revenue increased 18.7% to a record $16.3 million in Q2 FY 2025, from $13.7 million in the second quarter of the prior fiscal year. Operating income increased to a record $2.5 million, 15.6% of net revenues and a year-over-year increase of 12.3%. Net income was $2.0 mill

Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 second quarter ended December 31, 2024, on February 11, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Q2 Fiscal 2025 Webcast For tho

Electromed delivers eighth consecutive quarter of year-over-year revenue and profit growth, while continuing to invest in strategic growth initiatives Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2024 ("Q1 FY 2025"). Q1 FY 2025 Financial Highlights Net revenue increased 19.0% to $14.7 million in Q1 FY 2025, from $12.3 million in the first quarter of the prior fiscal year. Gross margin was 78.3% of net revenues, compared to 77.1% in the first quarter of the prior fiscal year. Operating income increased to $1.9 million or 13.2% of revenue compared to $0

Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 first quarter ended September 30, 2024, on November 12, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: https://viavid.webcasts.com/starthere.jsp?ei=

Record Q4 and full year financial results Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2024") and full year ("FY 2024") ended June 30, 2024. Q4 FY 2024 Financial Highlights Net revenues increased 9.0% to a record $14.8 million in Q4 FY 2024, from $13.6 million in the fourth quarter of the prior fiscal year. Gross margin was 76.2% of revenue, compared to 76.8% in the fourth quarter of the prior fiscal year. Operating income increased by 56.3% to a record $2.3 million or 15.7% of revenue, compared with $1.5 million or 11.0% of revenue in the fourth quarter of the p

Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 fourth quarter ended June 30, 2024, on August 27, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Q4 Fiscal 2024 Webcast F

Growth initiatives drive record revenue Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2024 ("Q3 FY 2024"). Q3 FY 2024 Financial Highlights Net revenues increased 15% to a record $13.9 million in Q3 FY 2024, from $12.1 million in the third quarter of the prior fiscal year. Gross margins were 75% of net revenues in the third quarters of both the current and prior fiscal years. Operating income increased by 54% to $1,841,000 or 13% of revenue, compared with $1,196,000 or 10% of revenue in the third quarter of the prior fiscal year. Net income was $1,493,00

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 third quarter ended March 31, 2024, on May 7, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: https://viavid.webcasts.

Growth initiatives drive record revenue, improve margins and enhance operational efficiency Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2023 ("Q2 FY 2024"). Q2 FY 2024 Financial Highlights Net revenue increased 17% to a record $13.7 million in Q2 FY 2024, from $11.7 million in the second quarter of the prior fiscal year. Gross margins were 77% of revenue, compared to 74% in the second quarter of the prior fiscal year. Operating income was a record $2,263,000 or 16.5% of revenue, compared with $1,274,000 or 10.1% of revenue in the seco

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 second quarter ended December 31, 2023, on February 13, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: https://viavid

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2023 ("Q1 FY 2024"). Q1 FY 2024 Financial Highlights Net revenue increased 16% to $12.3 million in Q1 FY 2024, from $10.7 million in the first quarter of the prior fiscal year. Operating income was $142,000, compared with $44,000 in the first quarter of the prior fiscal year. Net income was $155,000 for the quarter, or $0.02 per diluted share, compared to $81,000, or $0.01 per diluted share in the first quarter of the prior fiscal year. "The first quarter of our fiscal year ending June 30,

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 first quarter ended September 30, 2023, on Tuesday, November 7, 2023 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: https:

--Record Annual Revenue-- -- Fourth Quarter Revenue Increased 21% Year-Over-Year; Full Year Revenue Increased 15% -- Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2023") and full year ("FY 2023") ended June 30, 2023. Q4 FY 2023 Financial Highlights Net revenue increased 21% to a record $13.6 million in Q4 FY 2023, from $11.3 million in Q4 of the prior year. Operating income totaled $1.5 million in Q4 FY 2023, compared to $0.5 million in Q4 FY 2022. Net income was $1.0 million for the quarter, or $0.12 per diluted share, compared to $0.4 million,

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 fourth quarter and year ended June 30, 2023, on Tuesday, August 22, 2023 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: h

Quarterly Net Revenue Increase of 19% Year-over-Year Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2023 ("Q3 FY 2023"). Q3 FY 2023 Highlights Record quarterly net revenues of $12.1 million, a 19% year-over-year increase Homecare revenue of $11.0 million, an increase of 21% year-over-year Generated operating income of $1.2 million, an increase of 39% year-over-year Net income of $1.1 million, or $0.12 per fully diluted share, compared with net income of $645,000 in the same period a year ago Cash as of March 31, 2023 was $6.8 million "I'm very plea

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 third quarter ended March 31, 2023, on Tuesday, May 9, 2023 after the close of the stock market, and host a conference call at the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (888) 999-5318 (Domestic) or (848) 280-6460 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: https://viavid.webcasts.com/sta

Growth initiatives help drive record quarterly revenue Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2022 ("Q2 FY 2023"). Q2 FY 2023 Highlights Net revenue was $11.7 million for the three months ended December 31, 2022, a quarterly record and a 15% increase from $10.2 million for the three months ended December 31, 2021 ("Q2 FY 2022") Homecare revenue increased to $10.7 million in the quarter, up 14% from $9.4 million in Q2 FY 2022. Operating income increased to $1.3 million, compared to $1.1 million in Q2 FY 2022 Net income was $977,000, or $0.11 per dilu

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 second quarter ended December 31, 2022, on Tuesday, February 14, 2023 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: https://viavid.webcasts.co

Continued Momentum on Key Growth Initiatives Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2022 ("Q1 FY 2023"). Q1 FY 2023 Financial Highlights Net revenue was $10.7 million for the three months ended September 30, 2022, a 7% increase from $10.0 million for the three months ended September 30, 2021 ("Q1 FY 2022") Homecare revenue increased to $9.6 million in the quarter, up 4% from $9.3 million in Q1 FY 2022. Reported operating income of $44,000, compared to $538,000 in the same period a year ago, largely due to macroeconomic and supply cha

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 first quarter ended September 30, 2022, on Tuesday, November 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International), and using pin number 10172207. The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following li

--Record Annual Revenue and Growth Rate-- -- Fourth Quarter Revenue Increased 19% Year-Over-Year; Full Year Revenue Increased 16.5% -- -- Leveraging Strategic Investments to Accelerate Growth -- Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2022") and full year ("FY 2022") ended June 30, 2022. Q4 FY 2022 Financial Highlights Net revenue increased 19% to a record $11.3 million, from $9.5 million, for the three months ended June 30, 2022 ("Q4 FY 2022"), driven by 21.6% home care revenue growth. Operating income totaled $0.5 million, compared to $0.7 mill

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 fourth quarter and fiscal year 2022, ended June 30, 2022, after the close of the stock market on August 23, 2022. The Company will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International), and using pin number 13730926. The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly

15.4% revenue growth while continuing to execute key strategic initiatives Company also announces Chief Financial Officer transition Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for its fiscal 2022 third quarter ended March 31, 2022. Management will host a conference call at 5:00 p.m. Eastern Time today to discuss the results. Fiscal Third Quarter 2022 Highlights Recorded net revenues of $10.1 million in the quarter, a year-over-year increase of 15.4% driven by home care revenues of $9.0 million. Gross Profit was 76.4% of net revenues, compared with 76.3% of net revenues in the sa

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 third quarter ended March 31, 2022, on Tuesday, May 10, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International), and using pin number 13729193. The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: http

Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for its fiscal 2022 second quarter ended December 31, 2021. Management will host a conference call at 5:00 p.m. Eastern Time today to discuss the results. Fiscal Second Quarter 2022 Highlights Record net revenues of $10.2 million, compared with $9.5 million in the same period a year ago, driven by home care revenues of $9.4 million. Gross profit was 76.9% of net revenues, a decrease from 79.2% of net revenues in the same period a y

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on Tuesday, February 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (877) 407-0789 (Domestic) (201) 689-8562 (International) The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: https://viavid.webcasts.

-- Record quarterly revenue of $10.0 million, 25.0% growth vs. prior year driven by strong growth in home care and institutional markets -- Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2021 ("Q1 FY 2022"). Q1 FY 2022 Highlights Net revenue increased 25.0% to $10.0 million, from $8.0 million for the three months ended September 30, 2020 ("Q1 FY 2021"), driven by 24.4% home care revenue growth and 61.5% institutional revenue growth. Gross profit percentage increased to 77.0% of net revenue, from 76.8% of net revenue in Q1 FY 2021. The increase

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 first quarter ended September 30, 2021, on Tuesday, November 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (888) 428-7458 (Domestic) (862) 298-0702 (International) The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: https://78449.themediafram

-- Double-Digit Year over Year Revenue Growth -- -- Strong Operating Cash Flow -- -- Progress on Key Growth Initiatives: Commercial Expansion, Strategic Marketing, Research & Development, Infrastructure Investment -- -- Provides Update on Fiscal 2022 Strategic Priorities -- Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2021") and full year ("FY 2021") ended June 30, 2021. Q4 FY 2021 Financial Highlights Net revenue increased 37.7% to $9.5 million, from $6.9 million for the three months ended June 30, 2020 ("Q4 FY 2020"), driven by 33.6% home care revenue g

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 fourth quarter ended June 30, 2021, on Tuesday, August 24, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (877) 407-9753 (Domestic) (201) 493-6739 (International) The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: https://78449.themediaframe.com

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced select preliminary unaudited financial results for the three months ended June 30, 2021 ("Q4 FY 2021"). For Q4 FY 2021, the Company expects to report: Net revenue of between $9.3 million and $9.5 million, compared to $6.9 million for the three months ended June 30, 2020 ("Q4 FY 2020"), driven primarily by strong growth in home care revenue. Operating income of between $0.5 million and $0.7 million, compared to $1.3 million in Q4 FY 2020. The prior year period benefitted from $0.9 million of government stimulus income from the Provider Relief Fund establis

-- Second Consecutive Quarter of Year over Year Growth, Continuing Profitability & Positive Cash Flow while Investing in Key Strategic Initiatives -- Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced its financial results for the three months ended March 31, 2021 ("Q3 FY 2021"). Q3 FY 2021 Highlights Net revenue increased 0.5% to $8.8 million, compared to $8.7 million during the three months ended March 31, 2020 ("Q3 FY 2020"), driven by a 4.2% increase in home care revenue. Gross profit percentage increased to 76.3% of net revenue, compared to 75.4% in Q3 FY 2020, primarily due to a higher mix of home